- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: VGL101
Total 158 results
-
Alexey Danilov, MDGilead Sciences; Oregon Health and Science UniversityCompletedAnemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Grade 1 Follicular... and other conditionsUnited States
-
PrECOG, LLC.Genentech, Inc.TerminatedIndolent Non-Hodgkin's LymphomaUnited States
-
Christine RyanGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Richter's TransformationUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaBelgium, Italy, Spain, United States, Canada, Sweden, Greece, Netherlands, Austria, Switzerland, Poland, Turkey, Croatia, Brazil, Argentina, Denmark, United Kingdom
-
French Innovative Leukemia OrganisationRoche Pharma AG; Janssen-Cilag Ltd.Completed
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Italy, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Thailand, Romania, Croatia, Brazil, Arge... and more
-
Genentech, Inc.CompletedLymphocytic Leukemia, ChronicUnited States
-
WestVac Biopharma Co., Ltd.Not yet recruiting
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage III Prostate CancerChina
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Italy, Thailand, Romania, Croatia, Brazil, Arge... and more
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaUnited States, France, Germany
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Italy, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Thailand, Romania, Croatia, Brazil, Arge... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingFatigue | Weight Loss | Fever | Splenomegaly | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1... and other conditionsUnited States
-
German CLL Study GroupActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Joseph TuscanoNational Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Tolera Therapeutics, IncUnknownEnd Stage Renal Disease | Renal TransplantUnited States
-
Hoffmann-La RocheCompletedLymphomaUnited States, Italy, Korea, Republic of, Australia, Canada, Czechia, Spain, United Kingdom, France, Germany, Hungary, Turkey, Netherlands
-
Emory UniversityNational Cancer Institute (NCI); AstraZenecaRecruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Lymphoproliferative Disorder | Indolent Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditionsUnited States
-
GC Cell CorporationUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingChronic Lymphocytic Leukemia (CLL)United States, Italy, Australia, Spain, France
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
Kerry RogersActive, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterLoxo Oncology, Inc.; The Leukemia and Lymphoma SocietyRecruiting
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter Syndrome | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...The First Affiliated Hospital of Soochow University; The Affiliated Hospital... and other collaboratorsActive, not recruitingProstatectomy | Oligometastatic Prostate Cancer | AbirateroneChina
-
Hoffmann-La RocheCompletedLupus NephritisUnited States, Colombia, Israel, Brazil, Argentina, Costa Rica, France, Italy, Mexico, Panama, Peru, Spain
-
University of ChicagoNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.; Pharmacyclics LLC.RecruitingNon-Hodgkin's Lymphoma | Indolent Non-hodgkin Lymphoma | Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage II Nodal Marginal Zone Lymphoma | Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma | Ann Arbor... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
Fondazione Italiana Linfomi ONLUSTerminated
-
The Lymphoma Academic Research OrganisationActive, not recruiting
-
Hoffmann-La RocheRecruitingSystemic Lupus ErythematosusBrazil, United States, Argentina, United Kingdom, New Zealand, Spain, Italy, Poland, South Africa, France, Mexico, Peru, Russian Federation, Czechia
-
Hoffmann-La RocheInstitute of Cancer Research, United Kingdom; German Low Grade Lymphoma Study...CompletedNon-Hodgkin's LymphomaItaly, Belgium, Canada, United Kingdom, Australia, China, Germany, United States, Russian Federation, Spain, Taiwan, Israel, Czechia, Hungary, Japan, France, Finland, Sweden
-
Hoffmann-La RocheFondazione Italiana Linfomi ONLUSTerminatedDiffuse Large B-Cell LymphomaItaly, China, Korea, Republic of, Canada, Australia, United States, Austria, Brazil, Denmark, Panama, Peru, Spain, Colombia, United Kingdom, Switzerland, Thailand, Mexico, Taiwan, Hong Kong, Russian Federation, Hungary, Japan, Germany, South Africa and more
-
Hoffmann-La RocheCompletedAdvanced Follicular LymphomaGermany, Brazil, United Kingdom, Spain, Japan, United States, Netherlands
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingLupus NephritisUnited States, Italy, Argentina, Germany, Colombia, South Africa, Poland, United Kingdom, Russian Federation, Brazil, France, Peru, Spain, Israel, Mexico
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel